Effect of a HEART Care Pathway on Chest Pain Management Within an Integrated Health System.


Journal

Annals of emergency medicine
ISSN: 1097-6760
Titre abrégé: Ann Emerg Med
Pays: United States
ID NLM: 8002646

Informations de publication

Date de publication:
08 2019
Historique:
received: 12 09 2018
revised: 17 12 2018
accepted: 31 12 2018
pubmed: 25 2 2019
medline: 13 3 2020
entrez: 25 2 2019
Statut: ppublish

Résumé

We describe the association of implementing a History, ECG, Age, Risk Factors, and Troponin (HEART) care pathway on use of hospital care and noninvasive stress testing, as well as 30-day patient outcomes in community emergency departments (EDs). We performed a prospective interrupted-time-series study of adult encounters for patients evaluated for suspected acute coronary syndrome. The primary outcome was hospitalization or observation, noninvasive stress testing, or both within 30 days. The secondary outcome was 30-day all-cause mortality or acute myocardial infarction. A generalized estimating equation segmented logistic regression model was used to compare the odds of the primary outcome before and after HEART implementation. All models were adjusted for patient and facility characteristics and fit with physicians as a clustering variable. A total of 65,393 ED encounters (before, 30,522; after, 34,871) were included in the study. Overall, 33.5% (before, 35.5%; after, 31.8%) of ED chest pain encounters resulted in hospitalization or observation, noninvasive stress testing, or both. Primary adjusted results found a significant decrease in the primary outcome postimplementation (odds ratio 0.984; 95% confidence interval [CI] 0.974 to 0.995). This resulted in an absolute adjusted month-to-month decrease of 4.39% (95% CI 3.72% to 5.07%) after 12 months' follow-up, with a continued trend downward. There was no difference in 30-day mortality or myocardial infarction (0.6% [before] versus 0.6% [after]; odds ratio 1.02; 95% CI 0.97 to 1.08). Implementation of a HEART pathway in the ED evaluation of patients with chest pain resulted in less inpatient care and noninvasive cardiac testing and was safe. Using HEART to risk stratify chest pain patients can improve the efficiency and quality of care.

Identifiants

pubmed: 30797573
pii: S0196-0644(19)30007-1
doi: 10.1016/j.annemergmed.2019.01.007
pmc: PMC6650318
mid: NIHMS1518104
pii:
doi:

Substances chimiques

Troponin 0

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

171-180

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL134647
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR001883
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.

Références

Circ Res. 2014 Jun 6;114(12):1959-75
pubmed: 24902978
BMJ Qual Saf. 2015 Dec;24(12):748-52
pubmed: 26316541
J Am Coll Cardiol. 2018 Feb 13;71(6):606-616
pubmed: 29420956
J Clin Pharm Ther. 2002 Aug;27(4):299-309
pubmed: 12174032
J Am Coll Cardiol. 2018 Oct 9;72(15):1875-1877
pubmed: 30286933
Crit Pathw Cardiol. 2013 Sep;12(3):121-6
pubmed: 23892941
JAMA. 2015 Nov 10;314(18):1955-65
pubmed: 26547467
JAMA Intern Med. 2015 Mar;175(3):428-36
pubmed: 25622287
Circulation. 2015 Nov 3;132(18 Suppl 2):S483-500
pubmed: 26472997
Med Care. 2017 Jul;55(7):698-705
pubmed: 28498196
Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2):195-203
pubmed: 25737484
Implement Sci. 2014 Jun 19;9:77
pubmed: 24943919
Health Aff (Millwood). 2014 Sep;33(9):1655-63
pubmed: 25201672
JAMA Intern Med. 2015 Jul;175(7):1207-12
pubmed: 25985100
JAMA Intern Med. 2014 Apr;174(4):546-53
pubmed: 24515551
Neth Heart J. 2008 Jun;16(6):191-6
pubmed: 18665203
J Clin Epidemiol. 2015 Mar;68(3):324-33
pubmed: 25499983
Ann Intern Med. 2017 May 16;166(10):689-697
pubmed: 28437795
Ann Emerg Med. 2018 Jan;71(1):54-63.e2
pubmed: 28739290

Auteurs

Adam L Sharp (AL)

Research and Evaluation Department, Kaiser Permanente Southern California, Pasadena, CA. Electronic address: adam.l.sharp@kp.org.

Aileen S Baecker (AS)

Research and Evaluation Department, Kaiser Permanente Southern California, Pasadena, CA.

Ernest Shen (E)

Research and Evaluation Department, Kaiser Permanente Southern California, Pasadena, CA.

Rita Redberg (R)

University of California, San Francisco, Department of Cardiology, San Francisco, CA.

Ming-Sum Lee (MS)

Los Angeles Medical Center, Division of Cardiology, Kaiser Permanente Southern California, Los Angeles, CA.

Maros Ferencik (M)

Knight Cardiovascular Institute, Oregon Health & Sciences University, Portland, OR.

Shaw Natsui (S)

University of California, Los Angeles, Department of Emergency Medicine, Los Angeles, CA.

Chengyi Zheng (C)

Research and Evaluation Department, Kaiser Permanente Southern California, Pasadena, CA.

Aniket Kawatkar (A)

Research and Evaluation Department, Kaiser Permanente Southern California, Pasadena, CA.

Michael K Gould (MK)

Research and Evaluation Department, Kaiser Permanente Southern California, Pasadena, CA.

Benjamin C Sun (BC)

Center for Policy Research-Emergency Medicine, Department of Emergency Medicine, Oregon Health & Sciences University, Portland, OR.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH